ReviewBiomedicines2025
HER2-Low Breast Cancer at the Interface of Pathology and Technology: Toward Precision Management.
Faezeh Shekari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewBiomedicines2025
Faezeh Shekari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.